Preparation method and application of multi-target complex antigen-loaded CD8+ cytotoxic T lymphocytes

A technology of lymphocytes and compound antigens, applied in the fields of biology and medicine, can solve the problem of tumor heterogeneity

Active Publication Date: 2018-04-13
BEIJING BIOHEALTHCARE BIOTECH
View PDF6 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

And tumor antigen peptides are restricted by MHC, only patients with the same MHC class I molecules can use the same peptide, and due to tumor heterogeneity, some tumor antigen peptides may induce immune tolerance instead of activating immune response

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method and application of multi-target complex antigen-loaded CD8+ cytotoxic T lymphocytes
  • Preparation method and application of multi-target complex antigen-loaded CD8+ cytotoxic T lymphocytes
  • Preparation method and application of multi-target complex antigen-loaded CD8+ cytotoxic T lymphocytes

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0069] Example 1 Construction of lentiviral LentihGM-CSF vector

[0070] PCR primers were provided for the CDS region sequence of human peripheral blood hGM-CSF gene (GeneID: NM_000758.3), and restriction sites were added to the 5' and 3' ends of the above gene by PCR amplification, and the plasmid pORFhGM-CSF (purchased from Invivogen, article number: porf-hgmcsf) was used as a template, and the hGM-CSF gene fragment was amplified by the PCR method; the hGM-CSF gene was directional cloned into the lentiviral ligated vector system ( figure 1 Shown) to construct the recombinant vector FattbC31UGW-hGM-CSF. The recombinant vector FattbC31UGW-hGM-CSF and envelope plasmid VSVG ( figure 2 shown) and the packaging structure plasmid CMVΔ8.9-D64N / D116N ( image 3 shown) mixed with a mixing ratio of 1.5-10:1-5:1 to form a lentiviral vector system, transfected on 293T cells with liposome LipofectamineTM, observed under a fluorescence microscope after 24-48 hours, and a large amount o...

Embodiment 2

[0077] Example 2 Synthesis of Multi-target Compound Antigen Peptides

[0078] The polypeptide shown in SEQ ID NO: 5 was entrusted to Shanghai Qiangyao Biotechnology Co., Ltd. to synthesize it using a standard Fmoc protocol, and to use high performance liquid chromatography for purification and purity analysis, and mass spectrometry for identification and molecular weight determination. The result shows that the purity of the polypeptide is higher than 95%, and the molecular weight is consistent with the theoretical value.

[0079] Specific synthesis steps: 1. Fmoc-protected columns and monomers must be protected by an alkaline solvent (such as piperidine) to remove the amino protection group; 2. Use an activator to activate and dissolve the carboxyl end of the amino acid that needs to be cross-linked, and convert the activated mono The body and the free amino group are cross-linked under the action of a cross-linking agent to form a peptide bond; 3. The first two steps are rep...

Embodiment 3

[0080] Example 3 Synthesis of Multi-target Compound Antigen Peptides

[0081] The polypeptide shown in SEQ ID NO: 10 was entrusted to Shanghai Qiangyao Biotechnology Co., Ltd. to synthesize it using a standard Fmoc protocol, and to use high performance liquid chromatography for purification and purity analysis, and mass spectrometry for identification and molecular weight determination. The result shows that the purity of the polypeptide is higher than 95%, and the molecular weight is consistent with the theoretical value. Specific synthesis steps: 1. Fmoc-protected columns and monomers must be protected by an alkaline solvent (such as piperidine) to remove the amino protection group; 2. Use an activator to activate and dissolve the carboxyl end of the amino acid that needs to be cross-linked, and convert the activated mono The body and the free amino group are cross-linked under the action of a cross-linking agent to form a peptide bond; 3. The first two steps are repeated un...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The present invention provides a multi-target compound antigen, that is, a combined CTL antigen epitope peptide, a multivalent vaccine targeting multiple sites on the surface of tumor cells, a multi-target compound antigen loaded with CD8+ cytotoxic T lymphocytes, Its preparation method and its application in the preparation of medicines for treating cancer. The invention also provides an epitope-induced specific CTL effector cell.

Description

[0001] Technical field: the present invention relates to the fields of biology and medicine, and more specifically relates to multi-target composite antigen-loaded CD8 + Preparation method and application of cytotoxic T lymphocytes. Background technique: [0002] Malignant tumors are one of the major diseases that threaten human health. In recent years, the important role of the immune system in tumor prevention and treatment has been widely recognized. Immunotherapy based on anti-tumor specific immune reconstitution is currently recognized internationally following surgery, After radiotherapy and chemotherapy, the most promising means of completely eradicating tumor cells in the body to cure tumors will become a major direction of future tumor treatment. Immunotherapy mainly activates and mobilizes cytotoxic and biologically active cells and cytokines by supplementing, inducing and activating the body's inherent biological response regulation system in vitro, improves the fun...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07K19/00C12N5/0783C12N5/10C12N15/867A61K39/00A61P35/00
Inventor 刘静维卢戌王跃杨照敏
Owner BEIJING BIOHEALTHCARE BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap